A detailed history of Dunhill Financial, LLC transactions in Insulet Corp stock. As of the latest transaction made, Dunhill Financial, LLC holds 7 shares of PODD stock, worth $1,675. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7
Previous 6 16.67%
Holding current value
$1,675
Previous $952,000 46.85%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$161.02 - $206.98 $161 - $206
1 Added 16.67%
7 $1.4 Million
Q1 2024

May 13, 2024

BUY
$163.6 - $209.11 $163 - $209
1 Added 20.0%
6 $952,000
Q4 2023

Feb 12, 2024

BUY
$127.77 - $221.42 $638 - $1,107
5 New
5 $1.01 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $16.6B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Dunhill Financial, LLC Portfolio

Follow Dunhill Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dunhill Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dunhill Financial, LLC with notifications on news.